Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Clinical Gastroenterology

• Publication date

  1992-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004836-199210000-00004PMID 1479161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Failure of initial 24-hour esophageal pH monitoring to predict refractoriness and intractability in reflux esophagitis.

  1991cited by this paper
• Long-term maintenance treatment of reflux esophagitis with omeprazole

  1991cited by this paper
• Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.

  1991cited by this paper
• 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.

  1991cited by this paper
• Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.

  1990cited by this paper
• Pattern of acid reflux in patients with reflux esophagitis 'resistant' to H2-receptor antagonists.

  1990cited by this paper
• The medical management of reflux esophagitis. Role of antacids and acid inhibition.

  1990cited by this paper
• Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.

  1990cited by this paper
• Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2‐receptor antagonists

  1990cited by this paper
• Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2)

  1990cited by this paper
• Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.

  1990cited by this paper
• Gastric acid hypersecretion in refractory gastroesophageal reflux disease.

  1990cited by this paper
• Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

  1990cited by this paper
• Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.

  1990cited by this paper
• Omeprazole in H2 Receptor Antagonist‐Resistant Reflux Esophagitis

  1990cited by this paper
• Management of gastro-oesophageal reflux disease. Are there alternatives to omeprazole?

  1989cited by this paper
• Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.

  1989cited by this paper
• Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole.

  1989cited by this paper
• H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?

  1987cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper

• Microanatomical effects of ß, ɛ-carotene-3,3′-diol on indomethacin induced gastric ulcer in male wistar rats

  2025cites this paper
• A Comprehensive Review on Omeprazole: Pharmacological Effects and Its Adverse Effects

  2025cites this paper
• The Discrepancy Between Subjective and Objective Clinical Endpoints in Gastroesophageal Reflux Disease

  2022cites this paper
• Vonoprazan versus proton‐pump inhibitors for healing gastroesophageal reflux disease: A systematic review

  2019cites this paper
• Gastro-oesophageal reflux. Part 2: medical treatment.

  2013cites this paper
• Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis

  2010cites this paper
• Acid-Suppressive Effects of Various Regimens of Omeprazole in Helicobacter pylori-Negative CYP2C19 Homozygous Extensive Metabolizers: Which Regimen Has the Strongest Effect?

  2007cites this paper
• Which Has Superior Acid-Suppressive Effect, 10 Mg Omeprazole Once Daily or 20 Mg Famotidine Twice Daily? Effects of Single or Repeated Administration in Japanese Helicobacter Pylori-Negative CYP2C19 Extensive Metabolizers

  2007cites this paper
• Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.

  2005cites this paper
• Title Hepatic tight junctions : From viral entry to cancer metastasis

  2005cites this paper
• Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: A

  2005cites this paper
• Short‐term cost effectiveness and long‐term cost analysis comparing laparoscopic Nissen fundoplication with proton‐pump inhibitor maintenance for gastro‐oesophageal reflux disease

  2005cites this paper
• Histological Esophagitis (Clinical and Histological Response to Omeprazole in Children)

  2004cites this paper
• Examinations and Medical Therapy for GERD

  2003cites this paper
• Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2‐receptor antagonist

  2003cites this paper
• In Support of “ Step-Up Therapy ” for Gastroesophageal Reflux Disease TO THE

  2002cites this paper
• troglitazone : Report of two cases and review of adverse events reported to the United States Food and Drug Administration

  2002cites this paper
• Clostridium difficile-associated diarrhea in patients with HIV: a 4-year survey.

  2002cites this paper
• Cost-effectiveness and cost-utility of long-term management strategies for heartburn.

  2002cites this paper
• Gastroesophageal Reflux Disease

  2001cites this paper
• Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.

  2001cites this paper
• A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

  2000cites this paper
• Appropriateness of omeprazole prescribing in Quebec's senior population.

  2000cites this paper
• Medical Therapy of Gastroesophageal Reflux Disease

  2000cites this paper
• pH, healing rate, and symptom relief in patients with GERD.

  1999cites this paper
• Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis

  1999cites this paper
• [Can the spontaneous course of gastroesophageal reflux be predicted and the therapeutic response?].

  1999cites this paper
• Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease—a prospective, controlled trial

  1999cites this paper
• Proton-pump inhibitors for gastric acid-related disease.

  1998cites this paper
• Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost‐effectiveness analysis

  1998cites this paper
• Meta- Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD

  1998cites this paper
• Oesophageal Mucosal Diseases in the Elderly

  1998cites this paper
• Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis.

  1998cites this paper
• Current pharmacological treatment of reflux esophagitis.

  1998cites this paper
• Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisapride

  1997cites this paper
• Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi‐centre double‐blind study

  1997cites this paper
• Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis.

  1997cites this paper
• Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.

  1997cites this paper
• Gastroesophageal Reflux Disease

  1997cites this paper
• The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines.

  1996cites this paper
• Esophageal emergencies.

  1996cites this paper
• Gastroesophageal reflux disease

  1996cites this paper
• Principes thérapeutiques du reflux gastroœsophagien

  1995cites this paper
• Comparative Role of Omeprazole in The Treatment of Gastroesophageal Reflux Disease

  1995cites this paper
• Lansoprazole Versus Famotidine in Symptomatic Reflux Esophagitis: A Randomized, Multicenter Study

  1995cites this paper
• Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies

  1995cites this paper
• [Therapeutic principles in gastroesophageal reflux].

  1995cites this paper
• Drug Information Analysis Service

  1994cites this paper
• Combination sucralfate and histamine2-antagonist therapy.

  1994cites this paper
• Review article: drug therapy for reflux oesophagitis

  1994cites this paper
• Symptoms and disease severity in gastro-oesophageal reflux disease.

  1994cites this paper
• Rolling review: gastro‐oesophageal reflux disease

  1993cites this paper
• Rationale and efficacy of medical therapy for gastroesophageal reflux disease

  1993cites this paper
• Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

  1991cites this paper